JERONIMO MARTIN/ADR (JRONY) Raised to “Buy” at Zacks Investment Research

Share on StockTwits

Zacks Investment Research upgraded shares of JERONIMO MARTIN/ADR (OTCMKTS:JRONY) from a sell rating to a buy rating in a research note released on Thursday morning. They currently have $32.00 price target on the stock.

According to Zacks, “Jeronimo Martins SGPS SA is engaged in the distribution and production of food items and fast moving consumer goods through its retail and wholesale operations in Portugal and Poland. The Company carries its operations through its distribution, manufacturing and service segments. It operates mini-hyper and hypermarkets, supermarkets and cash and carry outlets, food service platforms and also manufactures margarines, soups, savory products, ice tea and cooking oils. The Company also represents and caterers products ranging from cosmetics to chocolates, ice-creams and confectionaries. It is also engaged in the development of a chain of coffee kiosks and restaurants. Jeronimo Martins SGPS SA is headquartered in Lisbon, Portugal. “

Shares of JERONIMO MARTIN/ADR stock opened at $28.81 on Thursday. The stock has a market capitalization of $9.07 billion, a PE ratio of 20.73, a PEG ratio of 3.37 and a beta of 1.10. JERONIMO MARTIN/ADR has a one year low of $27.21 and a one year high of $43.49. The company has a debt-to-equity ratio of 0.12, a quick ratio of 0.27 and a current ratio of 0.48.

JERONIMO MARTIN/ADR Company Profile

Jerónimo Martins, SGPS, SA operates in the food distribution and specialized retail sectors in Portugal, Poland, and Colombia. The company operates through three segments: Food Distribution, Specialised Retail, and Agro Business. It operates 2,823 food stores under the Biedronka name; and a chain of 182 stores in the drugstore sector under the Hebe banner in Poland, as well as 389 food stores under the Ara name in Colombia.

Further Reading: Trading Penny Stocks

Get a free copy of the Zacks research report on JERONIMO MARTIN/ADR (JRONY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for JERONIMO MARTIN/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JERONIMO MARTIN/ADR and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

-$0.77 EPS Expected for Akebia Therapeutics Inc  This Quarter
-$0.77 EPS Expected for Akebia Therapeutics Inc This Quarter
Culp, Inc.  Given Average Recommendation of “Buy” by Analysts
Culp, Inc. Given Average Recommendation of “Buy” by Analysts
Erie Indemnity  Receives Average Recommendation of “Strong Buy” from Brokerages
Erie Indemnity Receives Average Recommendation of “Strong Buy” from Brokerages
MCO  Trading Down 4.1% Over Last 7 Days
MCO Trading Down 4.1% Over Last 7 Days
MindCoin  Price Tops $0.0028
MindCoin Price Tops $0.0028
Lowe’s Companies  Given “Outperform” Rating at Robert W. Baird
Lowe’s Companies Given “Outperform” Rating at Robert W. Baird


Leave a Reply

© 2006-2018 Ticker Report. Google+.